Skip to main content
Premium Trial:

Request an Annual Quote

Brooks Completes $79M Purchase of Nexus Biosystems

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Brooks Automation said that it has completed its $79 million acquisition of automated compound and sample management solution company Nexus Biosystems.

Based in Poway, Calif., Nexus' offerings include systems for sample management, storage, and retrieval, microplates, and products for protein crystallization.

Brooks is headquartered in Chelmsford, Mass., and provides automation, vacuum, and instrumentation solutions. In a statement, Steve Schwartz, president and CEO of Brooks, said that he plans to build the company into "the market and innovation leader in biobanking and compound sample management.

"With Nexus' operations on the West Coast and meaningful sales and service locations in Switzerland, Japan, and Germany complementing our existing life science systems' direct present on the East Coast and in the UK, we will have broad global reach," he said.

Nexus was formed in 2005 by the buy-out of certain assets from Discovery Partners, and its customers include the genomics, pharmaceutical, biotechnology, and biorepository industries. Last year, it acquired Remp, a supplier of automated systems for the life science industry, as well as the sample management business of Tecan. In 2009 it bought microplate firm Aurora Biotechnologies.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.